Cell membrane permeability enhancement via ultrasound-induced cavitation (null)

Cell membrane permeability enhancement via ultrasound-induced cavitation refers to the use of focused ultrasound energy—often combined with microbubble contrast agents—to temporarily disrupt the integrity of cellular membranes through mechanical effects known as *cavitation*. During this process, oscillating microbubbles generate localized shear forces that create transient pores ("sonoporation") in the lipid bilayer. This enables otherwise impermeable molecules—including large proteins, nucleic acids, nanoparticles, and chemotherapeutic agents—to enter cells efficiently. The effect is highly dependent on acoustic parameters such as frequency, intensity/pressure amplitude, exposure duration, presence/concentration of microbubbles/nanocarriers, and tissue type. At appropriate settings (low-to-moderate intensity), sonoporation is largely reversible with minimal cytotoxicity; however, excessive energy can cause irreversible damage through inertial cavitation. Clinically and preclinically this approach has been explored for enhancing drug/gene delivery across biological barriers—including tumor tissues and even the blood-brain barrier—with ongoing research into optimizing safety profiles and therapeutic efficacy.[1][4][5][7]

Other names

SonoporationUltrasound-mediated membrane permeabilizationUltrasound-enhanced cell permeabilityCavitation-induced membrane poration

Not applicable in the traditional sense. The mechanism involves physical disruption of the lipid bilayer by oscillating microbubbles generated during ultrasound exposure ("cavitation"), leading to transient pore formation ("sonoporation") that allows extracellular molecules/drugs to enter cells[1][5]. This can be reversible (stable cavitation) or destructive at higher intensities (inertial cavitation)[2][3].